Aligos Therapeutics (ALGS) Tax Rate (2020 - 2026)
Aligos Therapeutics' (ALGS) quarterly Tax Rate came in at 1.4% in Q1 2026, down 149.0% YoY from 2.85% in Q1 2025, and down 823.11% on a QoQ basis from 0.15% in Q4 2025.
Aligos Therapeutics (ALGS) Tax Rate (2020 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 7 years of Tax Rate data on file, last reported at 1.4% in Q1 2026.
- Quarterly Tax Rate fell 149.0% year-over-year to 1.4% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.66% (up 1.0% YoY) and the FY2025 annual result came in at 1.31%, down 106.0% from the prior year.
- Tax Rate slipped to 1.4% in Q1 2026, from 0.15% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 3.6% in Q2 2024 to a low of 4.2% in Q2 2023.
- A 5-year average of 0.27% and a median of 0.16% in 2023 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate jumped 780 bps — and 2025, when it sank 478 bps.
- Tracing ALGS's Tax Rate over 5 years: stood at 0.22% in 2022, then surged by 148 bps to 0.11% in 2023, then plunged by 131 bps to 0.03% in 2024, then sank by 360 bps to 0.15% in 2025, then slumped by 823 bps to 1.4% in 2026.
- The last three Tax Rate figures came in at 1.4% (Q1 2026), 0.15% (Q4 2025), and 0.18% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | - |
| 10 | Aligos Therapeutics | 68.32 Mn | 37.88 Mn | - | 215.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 215.07% |
| Jun 30, 2026 | 215.07% |
| Jun 30, 2026 | 215.07% |
| Mar 31, 2026 | -1.40% |
| Mar 31, 2026 | -1.40% |
| Mar 31, 2026 | -1.40% |
| Dec 31, 2025 | -0.15% |
| Dec 31, 2025 | -0.15% |
| Dec 31, 2025 | -0.15% |
| Sep 30, 2025 | -0.18% |
| Sep 30, 2025 | -0.18% |
| Sep 30, 2025 | -0.18% |
| Jun 30, 2025 | -1.18% |
| Jun 30, 2025 | -1.18% |
| Jun 30, 2025 | -1.18% |
| Mar 31, 2025 | 0.10% |
| Mar 31, 2025 | 0.10% |
| Mar 31, 2025 | 0.10% |
| Dec 31, 2024 | -0.03% |
| Dec 31, 2024 | -0.03% |